Successful Treatment with Atomoxetine of an Adolescent Boy with Attention Deficit/Hyperactivity Disorder, Extreme Obesity, and Reduced Melanocortin 4 Receptor Function
Year: 2013
Type: article
Study design: Case Report
Abstract: OBJECTIVE: Recent case reports suggest a link between reduced melanocortinergic tone and both obesity and attention deficit / hyperactivity disorder (ADHD). We present the case of a 13-year-old, male, obese MC4R mutation carrier with ADHD. CASE REPORT: The boy carries a heterozygous mutation in the melanocortin 4 receptor gene (MC4R; Met281Val), that leads to a reduced receptor function. Dominant mutations of this type represent major gene effects for obesity. He participated in a lifestyle intervention program for obesity and received treatment with the selective norepinephrine re-uptake inhibitor atomoxetine for 31 months. The boy markedly reduced his BMI from 47.2 to 29.6 kg/m². CONCLUSION: Atomoxetine proved to efficiently reduce weight in a severely obese MC4R mutation carrier with ADHD. We briefly discuss possible mechanisms for our observation, including evidence for the functional connectivity between melanocortinergic, dopaminergic, and norepinephrinergic brain circuitries.
Source: Obesity Facts
DOI: 10.1159/000348792
Institutions: Philipps University of Marburg, University of Duisburg-Essen
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,590
Awards: Verbundprojekt Molekulare Mechanismen der Adipositas - Identifizierung von Kandidatengenen, Statistik und Koordination (Teilprojekt 1, WB2-C, WB3-C, Teilprojekt15b, Teilprojekt16), The Integrated Neurobiology of Food Intake, Addiction and Stress, Verbundvorhaben: Frühmanifeste Adipositas: Genetische Mechanismen und physiologische Implikationen, Teilprojekt 1
OpenAlex ID: W1992012100
